OZVONTI Trademark

Trademark Overview

On Tuesday, October 5, 2021, a trademark application was filed for OZVONTI with the United States Patent and Trademark Office. The USPTO has given the OZVONTI trademark a serial number of 97060091. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Tuesday, November 12, 2024. This trademark is owned by Spectrum Pharmaceuticals, Inc.. The OZVONTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment
ozvonti

General Information

Serial Number97060091
Word MarkOZVONTI
Filing DateTuesday, October 5, 2021
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2022

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpectrum Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSpectrum Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Friday, October 8, 2021NEW APPLICATION ENTERED
Friday, October 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2022ASSIGNED TO EXAMINER
Wednesday, July 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 16, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 16, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 10, 2023SOU EXTENSION 1 FILED
Monday, April 10, 2023SOU EXTENSION 1 GRANTED
Friday, July 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, October 5, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 10, 2024SOU EXTENSION 3 FILED
Wednesday, April 10, 2024SOU EXTENSION 3 GRANTED
Monday, November 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 12, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, November 12, 2024PETITION TO REVIVE-GRANTED
Tuesday, November 12, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, November 12, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, November 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, October 5, 2023SOU EXTENSION 2 FILED
Thursday, October 5, 2023SOU EXTENSION 2 GRANTED
Thursday, April 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ozvonti pharmaceuticals treatment oncological cancer